Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research symbols : Lly save search
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published: 2024-03-28 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.32%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.02%
H: 0.51%
C: -0.3%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: 0.26%
H: 2.03%
C: 1.57%
AMGN | News | $273.085 -0.17% -0.17% 2.5M
|
Health Technology
|
| O: 0.54%
H: 0.0%
C: 0.0%
antibody research global
Blacksmith Medicines to Present at the Gordon Research Conference on New Antibacterial Discovery and Development
Published: 2024-03-19 (Crawled : 15:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.55%
H: 2.03%
C: 1.89%
conference antibacterial research
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Published: 2024-03-13 (Crawled : 03:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
drug disease report research global market
Global IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2023-2029: Shift Towards Personalized Medicine and Targeted Therapies & Adoption of Biosimilars and Biobetters
Published: 2024-03-13 (Crawled : 01:00) - prnewswire.com
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: 0.0%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.07%
H: 0.09%
C: -0.7%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.66%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.59%
H: 0.01%
C: -1.45%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
report research global
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
Published: 2024-03-05 (Crawled : 22:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.86%
H: 0.45%
C: -0.58%
association cancer research meeting
Global Therapeutic Antibody Market Research Report 2024: Monoclonal, Bispecific, Drug Conjugates, Others Insights and Forecasts 2019-2029
Published: 2024-02-28 (Crawled : 03:00) - prnewswire.com
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.36%
H: 0.1%
C: -0.6%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.6%
H: 0.02%
C: -1.03%
drug report antibody research global market
Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: 3.06%
H: 0.0%
C: -2.34%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.23%
H: 1.16%
C: 0.08%
BMY | $48.86 -0.27% -0.02% 16M
|
Health Technology
|
| O: -0.19%
H: 0.23%
C: -2.02%
UTHR | $237.06 1.11% 1.09% 610K
|
Health Technology
|
| O: -0.48%
H: 1.17%
C: -1.04%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: 0.38%
H: 0.44%
C: -0.23%
reach research market
Global Incretin Based Drugs Research Report 2023: Market to Reach $64.28 Billion by 2029 from $40 Billion in 2022, Driven by Increasing Prevalence of Diabetes
Published: 2024-02-21 (Crawled : 02:00) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -0.88%
H: 1.75%
C: -0.29%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.65%
H: 0.62%
C: 0.5%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.01%
H: 1.1%
C: 1.1%
report reach research global diabetes market
Vanda Pharmaceuticals announces the publication of an article on The Efficacy of Tradipitant in Patients with Diabetic and Idiopathic Gastroparesis in Phase III Randomized Placebo-Controlled Clinical Trial
Published: 2024-01-25 (Crawled : 22:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -1.0%
H: 0.84%
C: 0.04%
VNDA | $4.57 -1.3% -1.31% 1.5M
|
Health Technology
|
| O: 2.72%
H: 0.53%
C: 0.53%
publication pharmaceuticals trial diabetic
Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting
Published: 2024-01-23 (Crawled : 17:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
genetic association positive research meeting trial therapy
Global Erectile Dysfunction Drugs Market Research Report 2024: Novel Drug Launches Propel Growth, Growing Geriatric Population Drives Demand - Forecast to 2034
Published: 2024-01-16 (Crawled : 00:00) - prnewswire.com
MGRX | $0.2824 -6.52% 24K
|
|
| O: 3.28%
H: 4.38%
C: -0.19%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
PTPI | $0.635 -6.63% -7.1% 180K
|
|
| O: 0.38%
H: 0.0%
C: -7.58%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
drug propel report research global growing market
Global Antibody Fragments Market Research Report 2023: Market to Reach $9.6 Billion by 2028 - Increasing Investments in Biopharmaceuticals Driving Growth
Published: 2024-01-15 (Crawled : 20:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -2.03%
H: 0.05%
C: 0.05%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.16%
H: 0.43%
C: 0.07%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.15%
H: 0.59%
C: -1.45%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.34%
H: 0.0%
C: 0.0%
investments report antibody reach research global growth market
ISOMORPHIC LABS ANNOUNCES STRATEGIC MULTI-TARGET RESEARCH COLLABORATION WITH LILLY
Published: 2024-01-07 (Crawled : 20:20) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
| Email alert
Add to watchlist
research collaboration
ProQR and Rett Syndrome Research Trust Join Forces with Axiomer™ RNA Editing Collaboration
Published: 2024-01-05 (Crawled : 12:00) - globenewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.08%
H: 0.97%
C: 0.74%
PRQR | News | $2.0 -0.99% -1.0% 36K
|
Health Technology
|
| O: 1.5%
H: 1.48%
C: -0.25%
research collaboration trust
Merck KGaA, Darmstadt, Germany, Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
Published: 2024-01-04 (Crawled : 20:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.22%
H: 1.78%
C: -1.72%
merck cancer agreement
Sitryx announces collaboration partner Lilly has commenced a Phase 1 study of SIT-011 for chronic autoimmune and inflammatory diseases
Published: 2024-01-04 (Crawled : 09:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 1.22%
H: 1.78%
C: -1.72%
sit-011 collaboration study
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -3.0%
H: 2.15%
C: 2.15%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -0.44%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.31%
H: 0.56%
C: -0.17%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.23%
H: 0.28%
C: -0.11%
reach research market
Vanqua Bio Advances Clinical Candidate for Parkinson’s Disease, Expands Leadership Team to Support Further Development
Published: 2023-12-12 (Crawled : 17:00) - biospace.com/
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
candidate parkinson’s
Parkinson's Disease Therapeutics Market revenue to hit USD 12.32 Billion by 2033, Says We Market Research
Published: 2023-12-06 (Crawled : 15:30) - prnewswire.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.64%
H: 0.0%
C: -1.33%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.52%
H: 0.18%
C: -0.43%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.03%
H: 0.28%
C: -0.41%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
DNLI | $15.55 -3.48% -3.6% 940K
|
Health Technology
|
| O: 0.05%
H: 5.74%
C: 3.18%
BIIB | $201.91 4.52% 4.32% 3.3M
|
Health Technology
|
| O: 0.42%
H: 2.37%
C: 1.45%
disease parkinson's revenue research therapeutics market
Global Cyclin-Dependent Kinase Inhibitor Drug Research Report 2023: Comprehensive Analysis of 45 Companies and 50+ Pipeline Drugs
Published: 2023-11-21 (Crawled : 18:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.44%
H: 0.63%
C: -0.05%
drug companies report pipeline research global
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.